AKT1 and breast cancer: Dysregulation of PI3K/AKT/mTOR-signaling is a regulator of aerobic glycolysis (194, 197–199) and provides scientific rational for controlling insulin-activation of PI3K/AKT/mTOR in both women with breast cancer and at-risk women.